idarucizumab - CISMeF

Preferred Label : idarucizumab;

MeSH hyponym : BI655075; BI 655075;

UNII : 97RWB5S1U6;

Origin ID

C000594745;

UMLS CUI

C3885063;

ATC code(s)
- idarucizumab [ATC Code]
Currated CISMeF NLP mapping
- Idarucizumab [NCIt concept]
- Idarucizumab [SMS substance]
- Idarucizumab [ICD-11 Extension code]
- Idarucizumab [Anticorps monoclonal]
- Idarucizumab (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- ADABI-FAB [MeSH concept]
- BI-655075 [MeSH concept]
- Praxbind [MeSH concept]
- idarucizumab [MeSH concept]
See also inter- (CISMeF)
- Anticoagulant reversal therapy [MedDRA LLT]
- Product containing idarucizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Idarucizumab [NCIt concept]
- Idarucizumab (substance) [SNOMED CT concept]
- Product containing idarucizumab (medicinal product) [SNOMED CT concept]
- idarucizumab [ATC Code]
Validated automatic mappings to BTNT
- idarucizumab [ATC Code]